Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ehret

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Brain Research Bulletin|January 1, 2003
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferentsA Birthelmer, A Ehret, F Amtage, et al.
Journal of Virology|September 1, 1996
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosisA Ehret, M O Westendorp, I Herr, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administrationCh Dittrich, G Greim, M Borner, et al.
The EMBO Journal|October 17, 1998
DEDD, a novel death effector domain-containing protein, targeted to the nucleolusA H Stegh, O Schickling, A Ehret, et al.
Journal of Thrombosis and Thrombolysis|February 26, 2024
Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesityJeffrey D Sperry, Aletha Loeb, Melissa J Smith, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Brain Research Bulletin|January 1, 2003
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferentsA Birthelmer, A Ehret, F Amtage, et al.
Journal of Virology|September 1, 1996
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosisA Ehret, M O Westendorp, I Herr, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2002
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administrationCh Dittrich, G Greim, M Borner, et al.
The EMBO Journal|October 17, 1998
DEDD, a novel death effector domain-containing protein, targeted to the nucleolusA H Stegh, O Schickling, A Ehret, et al.
Journal of Thrombosis and Thrombolysis|February 26, 2024
Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesityJeffrey D Sperry, Aletha Loeb, Melissa J Smith, et al.
Pageof 2